Related Experiment Video

Updated: May 29, 2026

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
11:02

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on: October 30, 2013

Chemotherapy: Electromotive mitomycin in superficial bladder cancer

Willem Oosterlinck

    Nature Reviews. Clinical Oncology
    |September 14, 2011
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Electrochemotherapy of Tumours
    03:57

    Electrochemotherapy of Tumours

    Published on: December 15, 2008

    An Orthotopic Model of Murine Bladder Cancer
    09:07

    An Orthotopic Model of Murine Bladder Cancer

    Published on: February 6, 2011

    Related Experiment Videos

    Last Updated: May 29, 2026

    Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
    11:02

    Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

    Published on: October 30, 2013

    Electrochemotherapy of Tumours
    03:57

    Electrochemotherapy of Tumours

    Published on: December 15, 2008

    An Orthotopic Model of Murine Bladder Cancer
    09:07

    An Orthotopic Model of Murine Bladder Cancer

    Published on: February 6, 2011

    Related Concept Videos

    Targeted Cancer Therapies02:57

    Targeted Cancer Therapies

    The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
    There are several types of targeted therapies against specific...

    Articles linked to this work by shared authors, journal, and citation graph.

    Urethroplasty for Failed Hypospadias Repair Related Strictures in Adults: A Retrospective Analysis With Long-term Follow-up.

    Urology·2020

    Independent risk factors for failure after anterior urethroplasty: a multivariate analysis on prospective data.

    World journal of urology·2020

    Primary versus Redo Urethroplasty: Results from a Single-Center Comparative Analysis.

    BioMed research international·2020

    Perineal Urethrostomy for Complicated Anterior Urethral Strictures: Indications and Patient's Choice. An Analysis at a Single Institution.

    Urology·2020

    A Comprehensive Review Emphasizing Anatomy, Etiology, Diagnosis, and Treatment of Male Urethral Stricture Disease.

    BioMed research international·2019

    Vessel-sparing Excision and Primary Anastomosis.

    Journal of visualized experiments : JoVE·2019

    Exploring the landscape of targetable alterations in patients with glioblastoma.

    Nature reviews. Clinical oncology·2026

    AI-based augmentation of oncology clinical trials.

    Nature reviews. Clinical oncology·2026

    Clinical toxicity of ADCs and ICI-ADC combinations: mechanisms, patterns and management.

    Nature reviews. Clinical oncology·2026

    De-escalation trials in multiple myeloma: past, present and future.

    Nature reviews. Clinical oncology·2026

    Towards liquid biopsy-based analysis of antitumour immunity.

    Nature reviews. Clinical oncology·2026

    CRISPR in clinical oncology: translational advances from molecular diagnostics to therapeutics.

    Nature reviews. Clinical oncology·2026

    Occurrence of Infusion Associated Reactions and Antidrug Antibodies in Enzyme Replacement Therapy for Fabry Disease and the Effect of Preventive Measures.

    Journal of inherited metabolic disease·2026

    NRAS knockdown reverses monocytic cell state and resensitizes resistant FLT3-AML cells to gilteritinib.

    Blood·2026

    Amyloid-Related Imaging Abnormalities Summit Special Proceedings: Cardiovascular and Stroke Considerations for β-Amyloid Immunotherapy in Alzheimer Disease.

    Journal of the American Heart Association·2026

    Inhibiting PIK3C3/VPS34 enhances anti-GD2 immunotherapy in neuroblastoma.

    Autophagy·2026

    Toward Personalized Theranostics: A Modular PET Platform for Antibody-Based Imaging and Therapy.

    Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026

    Targeted Degradation of KAT6A: Expanding the Therapeutic Frontier of Epigenetic Drug Discovery.

    ACS medicinal chemistry letters·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us